Review
Open access
Aug 2026
Molecular classification and precision therapy in gastric cancer: Current advances and future perspectives (Review)
Focusing on acquired resistance as a core bottleneck in precision therapy, mechanisms underlying anti-Human Epidermal Growth Factor Receptor 2 (HER2) resistance and primary/secondary resistance to immune checkpoint inhibitors (ICIs) were systematically dissected, while also addressing immune-related adverse events and pseudo-/hyperprogression.
Shu-Jing Xia, Xiumei Zhang, Li-Zhong Tang et al.
· Oncology Report · 0 citations